Why the study?
How should anticoagulation be managed in patients with atrial fibrillation and factor X deficiency?
How should anticoagulation be managed in patients with atrial fibrillation and factor X deficiency?
Highlights the management dilemma and potential treatment options for anticoagulation in patients with the rare combination of atrial fibrillation and factor X deficiency.
Answers are grounded in this paper and cite their sources.
No anticoagulation guidelines exist for FX deficiency; case experience extends options but leaves optimal strategies open.
Factor X (FX) deficiency is a rare bleeding disorder. There is currently no clear guideline or recommendation for the appropriate selection of anticoagulation and management of patients with FX deficiency who require anticoagulation. We shared our experience in managing such patient, and we further discussed other possible treatment options.
No takes yet. Share an insight, caveat, or question.
Tan et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: